Human hydroxysteroid (17-β) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts

Endocrinology

Volumn 147, Issue 11, 2006, Pages 5333-5339

  Husen, Bettina ^a   Huhtinen, Kaisa ^b   Saloniemi, Taija ^b   Messinger, Josef ^a   Thole, Hubert H ^a   Poutanen, Matti ^b  

^a Solvay Pharmaceuticals GmbH   (Germany)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE; OXIDOREDUCTASE INHIBITOR; RECOMBINANT ENZYME; RECOMBINANT HUMAN TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; ENZYME INHIBITORS; ESTRADIOL DEHYDROGENASES; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; TRANSPLANTATION, HETEROLOGOUS;

EID: 33751240474     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0778     Document Type: Article

References (21)

1. Mindnich R, Möller G, Adamski J 2004 The role of 17 β-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 218:7-20
2. Penning TM 2003 Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action. Hum Reprod Update 9:193-205
3. Bonney RC, Reed MJ, Davidson K, Beranek PA, James VH 1983 The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin Endocrinol (Oxf) 19:727-739
4. McNeill JM, Reed MJ, Beranek PA, Bonney RC, Ghilchik MW, Robinson DJ, James VH 1986 A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in postmenopausal women. Int J Cancer 38:193-196
5. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG, Nagura H 1996 Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab. 81:4042-4046
6. Poutanen M, Isomaa V, Lehto VP, Vihko R 1992 Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 50:386-390
7. Poirier D 2003 Inhibitors of 17β-hydroxysteroid dehydrogenases. Current Med Chem 10:453-477
8. Oduwole OO, Li Y, Isomaa VV, Mantyniemi A, Pulkka AE, Soini Y, Vihko PT 2004 17β-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer. Cancer Res 64:7604-76049
9. Gunnarsson C, Hellqvist E, Stal O 2005 17β-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer. Br J Cancer 92:547-552
10. Miettinen MM, Mustonen VJ, Poutanen MH, Isomaa VV, Vihko RK 1996 Human 17β-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression. Biochem J 314:839-845
11. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE 1998 Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolise 17β-estradiol. J Clin Endocrinol Metab 83:4474-4480
12. Shafie SM, Grantham FH 1981 Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Nat Cancer Inst 67:51-56
13. Noel A, Simon N, Raus J, Foidart JM 1992 Basement membrane components (Matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochem Pharmacol 43:1263-1267
14. Clarke R 1996 Human breast cancer cell line xenografts as models of breast cancer: the immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. Breast Cancer Res Treatment 39:69-86
15. Yue W, Zhou D, Chen S, Brodie A 1994 A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Res 54:5092-5095
16. Yue W, Wang JP, Hamilton CJ, Demers LM, Santen RJ 1998 In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res 58:927-932
17. Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T 2003 Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients. J Steroid Biochem Mol Biol 86:455-460
18. Messinger J, Thole HH, Husen B, Van Steen B, Schneider G, Hulshoff JBE, Koskimies P, Johansson N, Adamski J 2005 Novel 17β-hydroxysteroid dehydrogenase inhibitors, Patent WO 2005047303, pp 1-189
19. Miettinen MM, Poutanen MH, Vihko RK 1996 Characterization of estrogen dependent growth of cultured MCF-7 human breast-cancer cells expressing 17β-hydroxysteroid dehydrogenase type I. Int J Cancer 68:600-604
20. Li S, Martel C, Dauvois S, Belanger A, Labrie F 1994 Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer. Endocrinology 134:1352-1357
21. Nokelainen P, Puranen T, Peltoketo H, Orava M, Vihko P, Vihko R 1996 Molecular cloning of mouse 17β-hydroxysteroid dehydrogenase type 1 and characterization of enzyme activity. Eur J Biochem 236:482-490